About
Cord Blood Cell Therapy
Areas of Focus
Categories
Stem Cell & Cellular TherapySouthwestern U.S.
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
153
By Phase
PHASE1: 5
By Status
ACTIVE_NOT_RECRUITING: 2RECRUITING: 1WITHDRAWN: 1COMPLETED: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT05695521Lead Sponsor
Regulatory T Cells for Amyotrophic Lateral Sclerosis
PHASE1Active, not recruiting
66 participants
Started: Apr 3, 2023 · Completed: Dec 31, 2027
NCT05423691Lead Sponsor
Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs
PHASE1Recruiting
24 participants
Started: Dec 27, 2022 · Completed: Dec 30, 2026
NCT03773328Lead Sponsor
A Clinical Trial of CK0801 (a New Drug) In Patients With Treatment-Resistant Guillain-Barré Syndrome (GBS)
PHASE1Withdrawn
Started: Nov 30, 2022 · Completed: Feb 28, 2027
NCT04468971Lead Sponsor
REgulatory T Cell infuSion fOr Lung Injury Due to COVID-19 PnEumonia
PHASE1Completed
45 participants
Started: Sep 29, 2020 · Completed: Oct 22, 2021
NCT03773393Lead Sponsor
A Clinical Trial of CK0801 (a New Drug) in Patients With Bone Marrow Failure Syndrome (BMF)
PHASE1Active, not recruiting
18 participants
Started: May 30, 2019 · Completed: May 30, 2027
Locations (1)
Headquarters
Houston, TX, United States
Map
Loading map...